Shingrix
Should Patients Taking Immunomodulators Receive a Recombinant Shingles Vaccine?
Although immunocompromised patients should be vaccinated against shingles, according to the Advisory Committee on ...
JUNE 13, 2023
Shingles Vaccine Safe, Effective Up to 10 Years Post-Vaccination
The adjuvanted recombinant zoster vaccine (RZV; Shingrix, GSK) for shingles provides long-term protection against ...
DECEMBER 10, 2022
Shingles Vaccine Does Not Appear to Increase Flares in Immunomodulator Users
The varicella zoster vaccine, Shingrix, protects against shingles in people taking immunomodulators without causing ...
SEPTEMBER 30, 2022
Herpes Zoster and IBD: A Q&A With Francis A. Farraye, MD, MSc
In late July, GlaxoSmithKline announced that the FDA agreed to expand the product label for Shingrix, the ...
DECEMBER 17, 2021
Cancer Patients Face Higher Risk for Shingles
People newly diagnosed with cancer, particularly hematologic cancers, and those treated with chemotherapy have a ...
DECEMBER 26, 2018
ACIP Recommends New Shingles Vaccine
The ACIP recommended Shingrix vaccine to prevent herpes zoster and its related complications in immunocompetent ...
JANUARY 29, 2018
CDC’s ACIP Recommends Adding Shingrix to the Adult Vaccination Schedule
The committee voted to include Shingrix (GlaxoSmithKline) in the adult vaccination recommendations for to prevent ...
OCTOBER 26, 2017
FDA Approves Shingrix Shingles Vaccine
Shingrix is a recombinant subunit vaccine given intramuscularly in two doses that combines an antigen, glycoprotein ...
OCTOBER 24, 2017
